Literature / Brochures
Introduction to PCI Drug Development and Manufacturing Services
PCI provides full development and manufacturing services for both investigational and commercial products, including highly potent molecules requiring specialist handling.
With over 35 years of experience in processing potent and non-potent drug products, PCI provides a true partnership and consultative approach from pre-clinical formulation development and API characterization through to full commercial launch.
DOWNLOAD TO LEARN MORE>>>>
More Literature / Brochures by PCI Pharma Services
More Content From PCI Pharma Services
-
PCI’s Jeff Clement discusses key areas of investment and insight into recent sterile fill-finish and injectable packaging expansions.
-
Technological advancements, global market dynamics, and patient-centric approaches are all factors driving the transformation of the parenteral drug market.
-
Experts at PCI Pharma Services discuss trends and challenges associated with digital transformation in the pharmaceutical industry.
-
Tim Roberts, Chief Commercial Officer, PCI Pharma Services, discusses industry trends, growing business sectors, and key investments.
-
PCI Pharma Services’ Louise Carpenter outlines the vital role formulation development plays in the rapidly growing field of oncology outsourcing.
-
Shawn Cain, senior VP of development and manufacturing at PCI Pharma Services, discusses pharma and biopharma outsourcing trends.
-
Mitigate potential delays while awaiting IND approval with a Pre-IND strategy.
-
The following six strategies can be used to find balance; nevertheless, they all require the support of a trusted clinical packager.
-
-
Investigational Medicinal Products
-
-
-
-
Advanced Protection for Packaging of Sensitive Solid Doses
-
PCI Broadens Global Clinical Supply-Chain Service Offerings Into Mainland Europe